ArticleESMO open2026

Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

A Raimondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.